Long-term benefit of intravenous immunoglobulins in cadaveric kidney retransplantation

Transplantation

Volumn 62, Issue 11, 1996, Pages 1670-1673

  Peraldi, Marie Noëlle ^a   Akposso, Kodzo ^a   Haymann, Jean Philippe ^a   Flahaut, Antoine ^a   Marlin, Christiane ^a   Rondeau, Eric ^a   Sraer, Jean Daniel ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AZATHIOPRINE; CYCLOSPORIN; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISOLONE; THYMOCYTE ANTIBODY;

ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SURVIVAL RATE;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; CADAVER; FEMALE; GRAFT SURVIVAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY TRANSPLANTATION; LONG-TERM CARE; MALE; REOPERATION; SURVIVAL RATE;

EID: 0030479491     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612150-00024     Document Type: Article

References (24)

1. Gaston RS, Shroyer TW, Hudson SL, et al. Renal retransplantation: the role of race, quadruple immunosuppression, and the flow cytometry crossmatch. Transplantation 1994; 57: 47.
2. Stratta RJ, Oh CS, Sollinger HW, Pirsch JD, Kalayoglu M, Belzer FO. Kidney retransplantation in the cyclosporine ERA. Transplantation 1988; 45: 40.
3. Reed E, Hardy M, Benvenisty A, et al. Effect of anti-idiotypic antibodies to HLA on graft survival in renal allograft recipients. N Engl J Med 1987; 316: 1450.
4. Ascher NL, Ahrenholz DH, Simmons RL, Najarian JS. One hundred second renal allografts from a single transplantation institution. Transplantation 1979; 27: 30.
5. Deierhoi MH, Sollinger HW, Kalayoglu M, Belzer FO. Quadruple immunosuppression in 305 consecutive cadaver renal allografts. Clin Transplant 1987; 1: 71.
6. Spees K, Vaughn WK, McDonald JC. Why do secondary cadaver renal transplants succeed? J Urol 1983; 129: 484.
7. Sanfilippo F, Vaughn WK, Bollinger RR, Spees EK. Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation 1982; 34: 360.
8. Rondeau E, Fournier A, Kanfer A, Sraer JD. Polyvalent immunoglobulins in sensitised renal transplant recipients. Nephrol Dial Transplant 1991; 6: 675.
9. Kaveri S, Vassilev T, Hurez V, et al. Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use. J Clin Invest 1996; 97: 865.
10. Fehr J, Hoffmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gammaglobulin. N Engl J Med 1982; 306: 1254.
11. Bussel J, Lacezari P, Hilgartner M, et al. Reversal of neutropenia with intravenous gammaglobulin in auto-immune neutropenia of infancy. Blood 1983; 62: 398.
12. Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger VE. Antiidiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) for high-dose intravenous gammaglobulin. Lancet 1984; 120: 765.
13. Reed E, McNamus P, Jo E, et al. Prediction of humoral immune responses to HLA through antiidiotypic antibody studies. Transplant Proc 1989; 21: 708.
14. Tyan DB, Li VA, Czer L, Trento A, Jordan SC. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994; 57: 553.
15. Glotz D, Haymann JP, Sansonnetti N, et al. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). Transplantation 1993; 56: 335.
16. Rossi F, Dietrich G, Kazatchkine MD. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses. Immunol Rev 1989; 110: 135.
17. Haymann J Ph, Glotz D, Sansonnetti N, François A, Druet Ph, Bariéty J. Normal human polyclonal immunoglobulins for intravenous use (IVIg) contain anti-idiotypes directed against human anti-HLA antibodies. J Am Soc Nephrol 1993; 4: 939.
18. Ruiz de Souza V, Carreno MP, Kaveri SV, et al. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin). Eur J Immunol 1995; 25: 1267.
19. Andersson UG, Bjork L, Skansen-Saphir U, Andersonn JP. Down regulation of cytokine production and IL2 receptor expression by pooled human IgG. Immunology 1993; 79: 211.
20. Basta M, Dalakas MC. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994; 94: 1729.
21. Dawidson I, Sandor ZF, Coorpender L. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation 1992; 53: 774.
22. Peters TG, Shaver TR, Ames JE IV, Santiago-Delpin EA, Jones KW, Blanton JW. Cold ischemia and outcome in 17,937 cadaveric kidney transplants. Transplantation 1995; 59: 191.
23. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331: 365.
24. Brezis M, Rosen S. Hypoxia of the renal medulla: its implications for disease. N Engl J Med 1995; 332: 647.